Deep Learning-Enhanced 3D Imaging Unveils Semaglutide Impact on Cardiac Fibrosis
Sheyla Barrado Ballestero, Sarah Torp Yttergren, Max Hahn, Marie Biviano Rosenkilde, Ditte Marie Jensen, Michael Søberg Christensen, Louise Thisted, Heidi Lindgreen Holmberg, Geoffrey Teixeira, Tor Biering‐Sørensen, Casper Graversen Salinas, Urmas Roostalu
This paper develops a 3D imaging and deep learning method to quantify cardiac fibrosis in mice and shows semaglutide reduces hypertrophy and perivascular fibrosis but not replacement fibrosis.
British Journal of Pharmacology · Oct 21, 2025Peer-reviewedPathology